Clene Inc. (CLNN): Cash & Equivalents
$5.19M
As of 2025-12-31
$9.67M
As of 2026-06-30
-34.3%
3-year compound annual growth
-38.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.19M | -57.3% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $12.15M | -57.8% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $28.82M | +57.2% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $18.33M | -63.5% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $50.29M | -15.2% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $59.27M | +574.5% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $8.79M | n/a | 2021-03-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $5.19M | -57.3% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $15.96M | -1.6% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $69.6K | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $681.5K | +174.4% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $4.98M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $14.69M | -24.8% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $251.3K | -18.3% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
Compare CLNN, LSTA, RGBP, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗